Louis E. Metzger IV

Louis E. Metzger IV is the Co-Founder and CEO of Stealth Targeted Radiotherapeutics NewCo, a company that is currently in the fundraising stage.2 He has a background in biotech and deep tech, and is based in the San Diego Metropolitan area.23

Professional Background

Metzger has experience in various aspects of the biotechnology industry:

• Current Role: Co-Founder and CEO at Stealth Targeted Radiotherapeutics NewCo2
• Previous Experience: He has worked with companies such as Deep Views Inc. and Tierra Biosciences4
• Academic Background: Metzger is associated with the University of California, San Francisco2

Additional Roles and Interests

Beyond his primary role, Metzger is involved in other professional activities:

• Contributor: He writes for Forbes, likely on topics related to biotech and deep tech3
• Social Media Presence: Metzger is active on Twitter (X) where he discusses topics related to biotech and deep tech3

Company Focus

While specific details about Stealth Targeted Radiotherapeutics NewCo are limited, the company name suggests a focus on targeted radiotherapy, which aligns with current trends in cancer treatment:

• Radiopharmaceuticals: The company likely operates in the growing field of radiopharmaceuticals, which has seen significant investment from major pharmaceutical companies1
• Targeted Therapy: The "targeted" aspect of the company name indicates a focus on precision medicine approaches to cancer treatment1

It's worth noting that as the company is in a "stealth" mode and currently fundraising, detailed information about its specific products or technologies may not be publicly available.